Get informed when a big investor buys or sells
+ FollowOvervalued by 119.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $35.75 Million |
|---|---|
| Enterprise Value | $38.23 Million |
| Earnings per Share | $0.02 |
| Beta | 4.01 |
| Outstanding Shares | 17,700,077 |
| P/E Ratio | 118.82 |
|---|---|
| PEG | -133.18 |
| Price to Sales | - |
| Price to Book Ratio | -2.02 |
| Enterprise Value to Revenue | 16.78 |
| Enterprise Value to EBIT | 143.6 |
| Enterprise Value to Net Income | 126 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -12.81 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; an...